Rilematovir

JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.

1383450-81-4

≥ 2 years

>98% (HPLC)

500.92

C21H20ClF3N4O3S

Research use only, not for human use.

——

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1278880-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock

Ask

MBS1278880-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock

Ask

MBS7219610-01 48 Well

Ask

MBS7219610-02 96 Well

Ask

MBS7219610-03 5x 96 Well

Ask

MBS7219610-04 10x 96 Well

Ask